Concord Biotech is trading 6.18% upper at Rs 1,271.55 as compared to its last closing price. Concord Biotech has been trading in the price range of 1,281.00 & 1,192.35. Concord Biotech has given -11.07% in this year & 12.76% in the last 5 days. Concord Biotech has TTM P/E ratio 41.13 as compared to the sector P/E of 27.34.There are 4 analysts who have initiated coverage on Concord Biotech. There are 1 analysts who have given it a strong buy rating & 1 analysts have given it a buy rating. 0.00 analysts have given the stock a sell rating.The company posted a net profit of 88.79 Crores in its last quarter.Listed peers of Concord Biotech include Torrent Pharmaceuticals (1.23%), Cipla (-0.83%), Sun Pharmaceutical Industries (-0.45%).The Mutual Fund holding in Concord Biotech was at 4.30% in 31 Mar 2026. The MF holding has decreased from the last quarter. The FII holding in Concord Biotech was at 7.79% in 31 Mar 2026. The FII holding has increased from the last quarter.
Updated on Jun 10, 2026, 12:46 AM UTC
|
| ||||
|
| ||||
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Torrent Pharmaceuticals | Bullish | 4,466.30 | 1.23 | 1,51,490.31 | 67.32 | 17.1 | 0.83 | 17.62 |
| Cipla | Neutral | 1,376.75 | -0.83 | 1,11,145.89 | 22.95 | 3.87 | 0.87 | 0.81 |
| Sun Pharmaceutical Industries | Neutral | 1,780.50 | -0.45 | 4,27,406.59 | 36.24 | 5.77 | 0.92 | 0.50 |
| Divi's Laboratories | Bullish | 6,758.00 | 3.71 | 1,79,275.74 | 78.61 | 11.52 | 0.46 | 0.01 |
| Dr Reddy's Laboratories | Neutral | 1,268.75 | -0.55 | 1,05,954.44 | 18.63 | 3.14 | 0.63 | 2.34 |
| Meeting Date | Purpose |
|---|---|
| 2026-05-29 | Audited Results & Final Dividend |
| 2026-02-11 | Quarterly Results |
| 2025-11-13 | Quarterly Results |
| 2025-08-08 | Quarterly Results |
| 2025-05-29 | Audited Results & Final Dividend |
Concord Biotech is trading at 1271.55 as on Tue Jun 09 2026 10:29:46. This is 6.18% upper as compared to its previous closing price of 1197.50.
The market capitalization of Concord Biotech is 13289.16 Cr as on Tue Jun 09 2026 10:29:46.
The average broker rating on Concord Biotech is Buy. The breakup of analyst rating is given below -
The 52 wk high for Concord Biotech is 2149.90 whereas the 52 wk low is 987.05
Concord Biotech can be analyzed on the following key metrics -
Concord Biotech reported a net profit of 260.91 Cr in 2026.
The Mutual Fund Shareholding was 4.30% at the end of 31 Mar 2026.
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.